Plastic Surgery of Austin now offers Motiva breast implants and the Preservé™ tissue-preservation approach. Motiva brings a newer generation of silicone implant technology to the U.S.; Preservé describes how space is created for an implant while attempting to preserve native supporting tissues. Dr. Kaimana Chow is among a limited group of board-certified plastic surgeons in Austin and Texas selected and approved by Motiva/Establishment Labs to offer Preservé. For patients researching Motiva Preservé in Austin, the essential distinction is simple: the implant is the device, while Preservé is the surgical approach. Whether they belong in your plan depends on anatomy, goals, and an examination.
What Are Motiva Breast Implants?
Motiva is a breast implant platform developed by Establishment Labs. The FDA's PMA record P230005 covers Motiva SmoothSilk® Round and Motiva SmoothSilk® Round Ergonomix® for breast augmentation in women age 22 and older, including primary augmentation and revision augmentation. That indication should not be expanded to all Motiva devices marketed internationally or treated as blanket approval for reconstruction.
A useful consultation starts with the exact device name, not simply the brand. Ask to review the current patient labeling and decision checklist, including warnings, alternatives, and long-term obligations. FDA approval establishes a specific regulatory indication; it does not eliminate implant risks or identify the best choice for an individual patient.

Why Are Motiva Implants Different?
The engineering combines surface design, silicone gel characteristics, and shell construction. These features help explain how an implant is built and may behave. They are not promises about how a particular breast will look, feel, or heal.
SmoothSilk® Surface
SmoothSilk describes Motiva's controlled smooth surface architecture. Surface design is one part of the interaction between an implant and surrounding tissue. It should not be described as preventing capsular contracture, infection, inflammation, BIA-ALCL, or other complications. A brand name is not a substitute for a balanced risk discussion.
ProgressiveGel®
ProgressiveGel Plus in Round emphasizes shape stability; ProgressiveGel Ultima in Round Ergonomix is softer and more dynamic. Gel characteristics influence the balance between maintained fullness and redistribution with position. The surrounding breast tissue, implant dimensions, and pocket also influence what those differences mean on the body.
TrueMonobloc® and BluSeal®
TrueMonobloc describes the shell, patch, and gel working as an integrated unit. BluSeal is a visual barrier-layer integrity feature. Neither term means rupture-proof, and BluSeal is not a diagnostic test for an implanted device. These design concepts do not replace clinical assessment or recommended imaging when implant integrity is a concern.
Optional Qid / RFID Identification
Optional Qid technology is available across the labeled styles for implant identification and traceability. This passive RFID feature is not GPS, a location tracker, or a powered transmitter. Keep the implant identification card and tell imaging staff which device you have: device-specific MRI conditions and potential image artifacts must be considered rather than assuming every configuration is identical.
Motiva Round vs. Motiva Ergonomix
Motiva SmoothSilk Round
Round uses a firmer, more shape-stable gel characteristic. Depending on the patient's anatomy and implant dimensions, that can support more maintained upper-pole fullness. It does not necessarily create an exaggerated appearance; tissue coverage, proportions, and placement remain central to the visible result.
Motiva SmoothSilk Round Ergonomix
Round Ergonomix is also physically round. Its softer gel and one fewer shell layer distinguish its construction from Round and allow more dynamic behavior with gravity and position. In plain language, the gel can redistribute as the patient moves or reclines. This is not a fixed anatomical or conventional teardrop-shaped implant, nor a guarantee of natural movement in every patient.
| Consideration | Motiva Round | Motiva Round Ergonomix |
|---|---|---|
| Physical implant shape | Round | Round |
| Gel behavior | More shape-stable | Softer / more dynamic |
| Upper-pole character | Can maintain greater fullness | Can allow a softer transition |
| Movement with position | More structurally stable | Greater gel redistribution |
| Selection | Anatomy-specific | Anatomy-specific |
There is no universal winner. A patient seeking a defined upper breast contour may value one balance; another may prioritize a softer transition. Neither preference overrides adequate tissue coverage or appropriate dimensions. Comparing implants in isolation cannot reproduce their behavior after surgery.
What Is Motiva Preservé™?
Preservé is not simply another breast implant model. It is a tissue-preservation augmentation approach and platform organized around reducing unnecessary disruption of native breast structures. The aim is to create an appropriate implant pocket while respecting the tissues and supporting structures already present. Preservation describes an operative intention, not a promise that no tissue changes.
Controlled Space Creation, Not an Absence of Surgery
Conventional augmentation generally creates a pocket through surgical dissection. Preservé incorporates specialized Motiva instrumentation for channel creation and controlled tissue separation and elongation. The manufacturer's description includes a Channel Separator and Inflatable Balloon for controlled tissue expansion. These are concepts for understanding the platform, not instructions for performing surgery. Incisions, surgical judgment, and careful pocket planning are still required.
Motiva's international platform description includes the Motiva Insertion Sleeve and a no-touch insertion concept. Here, that means a reduced-handling philosophy, not a guarantee of freedom from contamination or infection; international device availability and outcome claims do not transfer to U.S. care. Implant choice and tissue coverage still need to match the space being created; preservation is not a reason to force an implant into an unsuitable anatomical plan.
An Important U.S. Product Distinction
International Preservé information may discuss Ergonomix2. Ergonomix2 is not FDA approved in the United States and is distinct from the U.S.-approved Round Ergonomix. Ask which specific implant and instruments are proposed for your procedure. Instrument registration is not FDA approval of a surgical procedure, and manufacturer authorization of a surgeon is not personal FDA approval.
How Does Preservé Differ From Traditional Breast Augmentation?
The difference centers on pocket creation and patient selection, not on whether one operation is careful and the other is not. Conventional augmentation remains an established, appropriate operation with broad indications. Revision surgery, a lift, or particular anatomical needs may call for a different strategy.
| Consideration | Traditional breast augmentation | Preservé concept |
|---|---|---|
| Pocket creation | Surgical dissection according to the operative plan | Specialized tissue-preservation instrumentation |
| Tissue management | Tissue division may be required for the planned correction | Designed to limit unnecessary tissue disruption |
| Pocket strategy | Multiple planes may be considered according to anatomy | Preservation-focused approach in selected anatomy |
| Implant selection | Individualized | Still individualized |
| Role | Established approach with broad indications | Specialized approach requiring suitable anatomy and training |
Descriptions such as minimally invasive breast augmentation need context: less tissue disruption is the design goal, not proof of less pain or fewer complications for every patient. Preservé is another surgical strategy, not a universal replacement. Breast preservation surgery in this cosmetic context should also not be confused with breast-conserving cancer treatment.
Why Surgeon Selection Matters With Preservé
Preservé involves specific surgeon education, specialized instruments, careful measurements, and appropriate patient selection. Access does not automatically follow from offering a Motiva implant. Dr. Kaimana Chow is among a limited group of board-certified plastic surgeons in Austin and Texas selected and approved by Motiva/Establishment Labs to offer the Preservé platform. This is manufacturer selection, separate from FDA device approval.
Learn about Dr. Kaimana Chow, board-certified by the American Board of Plastic Surgery, Harvard-trained, and trained in general surgery residency at UT Southwestern. Those credentials support the conversation; the operative recommendation must still follow an assessment of your anatomy rather than enthusiasm for a particular platform.
Who May Be a Candidate for Preservé?
An article cannot establish candidacy. Dr. Chow considers primary augmentation versus revision, previous breast surgery, existing breast tissue and its quality, soft-tissue coverage, skin elasticity, and chest and breast dimensions. Desired implant size and projection must be evaluated against what the tissue envelope can reasonably accommodate.
Ptosis, asymmetry, and whether a breast lift is needed also matter. An implant adds volume but does not reliably correct every pattern of breast descent. Prior scars or altered pockets may change the surgical requirements. Overall health, medications, nicotine exposure, healing considerations, and anesthesia planning belong in the same assessment. These are discussion factors, not rigid online eligibility rules.
What Preservé Does NOT Mean
Tissue-preserving does not mean scarless, incision-free, risk-free, pain-free, or complication-free. It does not mean no anesthesia or zero downtime. Preserved sensation, a natural result, prevention of capsular contracture, and avoidance of future revision surgery cannot be guaranteed. Recovery still requires a practical plan for work, lifting, exercise, and help at home.
Risks include bleeding, infection, altered sensation, asymmetry, implant malposition, rupture, and capsular contracture. Discuss implant-associated cancers and reported systemic symptoms with Dr. Chow as part of informed consent. Persistent swelling, a new mass, or new breast changes warrant assessment rather than reassurance based on a device's surface name.
Breast implants are not lifetime devices. Ongoing follow-up and imaging are part of ownership; implant exchange, revision, or removal may eventually be necessary. Review silicone implant surveillance recommendations and symptom-driven evaluation with Dr. Chow, and retain your device records. Future costs and the possibility of additional operations deserve consideration before the first surgery.
Motiva Preservé vs. Choosing a Motiva Implant
Motiva implant means the medical device. Preservé means the approach and platform used to perform augmentation. A patient can be interested in Motiva implants without being a candidate for Preservé. Separating those decisions allows a more useful consultation: which implant fits your goals, and which surgical strategy fits your tissues?

Choosing an Implant Is Still About Anatomy
Breast base width, chest-wall proportions, existing breast volume, soft-tissue thickness, and skin characteristics form the starting point. Desired volume, profile, projection, upper-pole fullness, movement, and implant position are considered together. Symmetry has anatomical limits, and the tissues will continue to change with aging, weight fluctuations, and pregnancy.
A photograph or cc number alone cannot select an implant, and this article does not prescribe a size. For the broader comparison of materials, dimensions, and choices, explore our breast implant options in Austin. Motiva is one part of that discussion, not a replacement for it.
Frequently Asked Questions
Are Motiva implants FDA approved?
Motiva SmoothSilk Round and SmoothSilk Round Ergonomix are FDA approved for primary and revision breast augmentation in women age 22 and older. This does not extend to every international Motiva device or establish a blanket reconstruction indication.
Is Preservé a different breast implant?
No. Preservé is a specialized tissue-preservation approach and instrumentation platform. Motiva implants are medical devices. Choosing a Motiva implant does not automatically mean that Preservé is appropriate for your anatomy.
Is Round Ergonomix a teardrop implant?
No. The U.S.-approved Round Ergonomix has a round shell. Its softer gel redistributes with gravity and position; it is not a fixed anatomical implant. Round Ergonomix is also distinct from Ergonomix2, which is not FDA approved in the United States.
Does Dr. Chow offer Motiva Preservé in Austin?
Yes. Plastic Surgery of Austin offers Motiva, and Dr. Kaimana Chow is among a limited group of board-certified plastic surgeons in Austin and Texas selected and approved by Motiva/Establishment Labs to offer Preservé. An examination is still needed to determine candidacy.
Does tissue preservation mean no scars or downtime?
No. Preservé remains surgery, with incisions, anesthesia planning, recovery restrictions, and implant-related risks. Neither a pain-free recovery nor preserved sensation, a natural result, or avoidance of future surgery can be guaranteed.
Can I choose my implant size online?
No article, photograph, or cc number can determine a suitable size. Dr. Chow evaluates breast width, tissue coverage, skin, proportions, and goals before discussing implant dimensions, placement, and alternatives.
Planning a Consultation in Austin
Review our breast augmentation overview for the wider surgical planning process. Bring your goals, prior operative records if available, health history, and questions about device labeling, pocket choice, anesthesia, recovery, and follow-up. Ask what would make another approach more appropriate.
To discuss Motiva Preservé in Austin, request a consultation with Dr. Chow. The purpose is not to commit to a platform before examination, but to understand the options, limitations, and long-term responsibilities of a plan tailored to you.
References
- FDA — Motiva SmoothSilk breast implants, PMA P230005
- FDA — Motiva physician labeling: indications, device design, warnings, and MRI information
- Motiva USA — Implant engineering for surgeons
- Motiva USA — Breast implant technology
- Motiva USA — Preservé platform and U.S. product limitations
- Motiva international — Preservé insertion sleeve and reduced-handling concept only; not U.S. device availability
- FDA — Risks and complications of breast implants
This article is for general educational purposes only and is not medical advice. Every patient's anatomy, health, treatment plan, recovery, risks, and results vary. Discuss your individual case with your surgeon.





